Peptide and Protein-Based Drug Chemistry

Peptide-based therapeutics offer high specificity and biological potency. Engineered peptide agonists enhance receptor activation in glucose-regulating pathways. Increasing protease resistance extends circulation time and therapeutic durability. Optimized secondary structure improves molecular stability during storage and administration. Enhanced receptor selectivity minimizes off-target interactions.

Peptide Engineering Framework:

  • Stability Enhancement Methods
  • Structural Optimization
  • Receptor Binding Control

    Related Conference of Peptide and Protein-Based Drug Chemistry

    January 19-20, 2026

    17th International Conference on Biofuels and Bioenergy

    Barcelona, Spain
    May 04-05, 2026

    7th International Conference on Drug Chemistry

    Paris, France
    July 23-24, 2026

    22nd World Congress on Structural Biology

    Aix-en-Provence, France
    September 03-04, 2026

    16th World Glycobiology Congress

    Aix-en-Provence, France
    September 21-22, 2026

    24th International Conference on Structural Biology

    Barcelona, Spain

    Peptide and Protein-Based Drug Chemistry Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in